Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
10/03/2023 22:52
March 10 (Reuters) - Fulcrum Therapeutics Inc FULC.O :
* FULCRUM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text for Eikon: ID:nGNX8FWlJp
Further company coverage: FULC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program